Evangeslista, Reon .
HRN: 26-79-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/12/2025
03/19/2025
IV
300mg
Q6
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes